Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

By Saarto Tiina   Vehmanen Leena   Virkkunen Pekka   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite

Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant Therapy

By Talvensaari-Mattila A.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 1, 2001-01 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

By Lobbezoo Dorien   Kampen Roel   Voogd Adri   Dercksen M.   den Berkmortel Franchette   Smilde Tineke   Wouw Agnes   Peters Frank   Riel Johanna   Peters Natascha   Boer Maaike   Borm George   Tjan-Heijnen Vivianne  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 507-514

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant clodronate in breast cancer

By Paterson Alexander  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 80-82

Informa Healthcare

Access to resources Recommend Favorite

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite